Literature DB >> 18331238

Is the Cancer of the Liver Italian Program system an adequate weighting for survival of hepatocellular carcinoma? Evaluation of intrascore prognostic value among 36 subgroups.

Chih-Yun Lin1, Kwong-Ming Kee, Jing-Houng Wang, Chuan-Mo Lee, Chao-Long Chen, Chi-Sin Changchien, Tsung-Hui Hu, Yu-Fan Cheng, Hsuan-Chih Hsu, Chih-Chi Wang, Tai-Yi Chen, Sheng-Nan Lu.   

Abstract

BACKGROUND: The Cancer of the Liver Italian Program (CLIP) staging system for hepatocellular carcinoma (HCC) was subdivided into 36 subgroups. We aimed to validate the prognostic value of CLIP scoring.
METHODS: This study included 3868 HCC cases treated between 1986 and 2002. Survival and prognostic impact of all subgroups were analysed.
RESULTS: In primary CLIP, comparisons of each score showed a significant difference (P<0.001) and exhibited a linear trend (P<0.001). A CLIP score of 0 was used as control group. Portal vein thrombosis, Child-Pugh B, alpha-fetoprotein (AFP) > or =400 ng/ml and multinodular with tumour extension < or =50% of the four subgroups with a CLIP score of 1 exhibited decreasing univariate hazard ratios and 95% confidence intervals, with values of 2.99 (2.05-4.37), 2.39 (2.00-2.86), 1.66 (1.40-1.96) and 1.39 (1.18-1.63) respectively. Homogeneity in the same score was evaluated by comparing subgroup survival curves. For scores 1-5, 83.3% (5/6), 57.1% (16/28), 24.4% (11/45), 3.6% (1/28) and 16.7% (1/6) pairs of survival curves significantly differed, respectively, with decreasing linear trend (P<0.001).
CONCLUSION: Different prognostic weighting of four predictive factors caused intrascore heterogeneity. Lower CLIP scores were associated with increased differences in intrascore. In conclusion, the CLIP staging scoring system is a reasonable ordinal scale, but the clinician must be aware of the heterogeneity of mortality risk within a given score.

Entities:  

Mesh:

Year:  2008        PMID: 18331238     DOI: 10.1111/j.1478-3231.2008.01702.x

Source DB:  PubMed          Journal:  Liver Int        ISSN: 1478-3223            Impact factor:   5.828


  12 in total

Review 1.  Staging systems of hepatocellular carcinoma: a review of literature.

Authors:  Marcello Maida; Emanuele Orlando; Calogero Cammà; Giuseppe Cabibbo
Journal:  World J Gastroenterol       Date:  2014-04-21       Impact factor: 5.742

Review 2.  Staging systems for hepatocellular carcinoma: Current status and future perspectives.

Authors:  Akiyoshi Kinoshita; Hiroshi Onoda; Nao Fushiya; Kazuhiko Koike; Hirokazu Nishino; Hisao Tajiri
Journal:  World J Hepatol       Date:  2015-03-27

3.  Hepatic resection versus transarterial chemoembolization for patients with Barcelona Clinic Liver Cancer intermediate stage Child-Pugh A hepatocellular carcinoma.

Authors:  Yin-Nong Zhao; Yong-Quan Zhang; Jia-Zhou Ye; Xing Liu; Hong-Zhi Yang; Feng-Yun Cong; Bang-De Xiang; Fei-Xiang Wu; Liang Ma; Le-Qun Li; Hai-Hong Ye
Journal:  Exp Ther Med       Date:  2016-10-17       Impact factor: 2.447

4.  Use of yttrium-90 microspheres in patients with advanced hepatocellular carcinoma and portal vein thrombosis.

Authors:  Andrea Lan Tsai; Charles T Burke; Andrew S Kennedy; Dominic T Moore; Matthew A Mauro; Robert D Dixon; Joseph M Stavas; Stephen A Bernard; Amir H Khandani; Bert H O'Neil
Journal:  J Vasc Interv Radiol       Date:  2010-08-05       Impact factor: 3.464

Review 5.  Hepatocellular carcinoma: From clinical practice to evidence-based treatment protocols.

Authors:  Danijel Galun; Dragan Basaric; Marinko Zuvela; Predrag Bulajic; Aleksandar Bogdanovic; Nemanja Bidzic; Miroslav Milicevic
Journal:  World J Hepatol       Date:  2015-09-18

6.  Validation of the 7th edition TNM staging system for hepatocellular carcinoma: an analysis of 8,828 patients in a single medical center.

Authors:  Kwong-Ming Kee; Jing-Houng Wang; Chih-Yun Lin; Chih-Chi Wang; Yu-Fan Cheng; Sheng-Nan Lu
Journal:  Dig Dis Sci       Date:  2013-05-24       Impact factor: 3.199

7.  Is there an optimal staging system or liver reserve model that can predict outcome in hepatocellular carcinoma?

Authors:  Veeravich Jaruvongvanich; Tomoki Sempokuya; Linda Wong
Journal:  J Gastrointest Oncol       Date:  2018-08

8.  A Powerful Nomogram Based on the Novel D-Index to Predict Prognosis After Surgical Resection of Hepatocellular Carcinoma.

Authors:  Xia Du; Cheng-Nan Guo; Xiao-Dong Bao
Journal:  Cancer Manag Res       Date:  2021-03-17       Impact factor: 3.989

9.  Survival after locoregional treatments for hepatocellular carcinoma: a cohort study in real-world patients.

Authors:  Simona Signoriello; Annalisa Annunziata; Nicola Lama; Giuseppe Signoriello; Paolo Chiodini; Ilario De Sio; Bruno Daniele; Giovanni G Di Costanzo; Fulvio Calise; Graziano Olivieri; Vincenzo Castaldo; Rosario Lanzetta; Guido Piai; Giampiero Marone; Mario Visconti; Mario Fusco; Massimo Di Maio; Francesco Perrone; Ciro Gallo; Giovanni B Gaeta
Journal:  ScientificWorldJournal       Date:  2012-05-03

10.  Prognostic scores for hepatocellular carcinoma: none is the winner.

Authors:  Calogero Cammà; Giuseppe Cabibbo
Journal:  Liver Int       Date:  2009-04       Impact factor: 5.828

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.